Small Methods:无痛皮肤贴剂促进脂肪转化,成功逆转肥胖!

2017-12-29 sunshine2015 来宝网

微针贴剂提供已知可将能量储存的白色脂肪转化为能量燃烧的棕色脂肪的药物。由新加坡南洋理工大学(新加坡南洋理工大学)科学家开发的这一创新方法在四周内减少了高脂饮食和脂肪量的30%以上的小鼠体重增加。

新补丁帮助将储存能量的脂肪转化为燃烧能量的脂肪】微针贴剂提供已知可将能量储存的白色脂肪转化为能量燃烧的棕色脂肪的药物。由新加坡南洋理工大学(新加坡南洋理工大学)科学家开发的这一创新方法在四周内减少了高脂饮食和脂肪量的30%以上的小鼠体重增加。

这种新型皮肤贴片含有数百个微型针头,每根都比人类头发更薄,上面装有药物β-3肾上腺素能受体激动剂或另一种叫做甲状腺激素T3三碘甲状腺原氨酸的药物。

当贴片被压入皮肤约2分钟时,这些微针会嵌入到皮肤中并从贴剂上分离,然后将其移除。

随着针降解,药物分子缓慢地扩散到皮肤层下面的储存能量的白色脂肪,变成能量燃烧的棕色脂肪。

棕色的脂肪被发现在婴儿身上,通过燃烧能量帮助婴儿保持温暖。随着人类年龄的增长,棕色脂肪的数量减少,并被内脏白色脂肪所取代。

南大陈鹏教授和徐晨杰助理教授最近在“小方法”期刊上发表了这一方法,可以解决世界性的肥胖问题,而不需要外科手术或口服药物治疗。

“随着小鼠皮肤中嵌入的微针,周围的脂肪在五天内开始变褐,这有助于增加小鼠的能量消耗,从而减少体内脂肪的增加,”徐教授说。

“我们在贴剂中使用的药物数量远远少于口服药物和注射剂量,这使药物成本降低,而我们的缓释设计则将其副作用降到最低。”徐教授说。

脂肪过量积累引起的肥胖是包括心脏病,中风和2型糖尿病在内的各种疾病的主要健康危险因素。据世界卫生组织估计,2016年全球有19亿成年人超重,其中6.5亿人肥胖。

研究肥胖症的生物技术专家陈教授说:“我们的目标是开发一种无痛的补丁,每个人都可以轻松使用,不显眼,而且价格合理。 “最重要的是,我们的解决方案旨在使用一个人自己的身体脂肪燃烧更多的能量,这是婴儿的一个自然过程。”

根据两位科学家在南大化学与生物医学工程学院的指导下,研究人员AUNG Than博士进行的实验表明,这种贴剂可以抑制喂食高脂肪饮食的小鼠的体重增加,并在四个星期的时间内将脂肪量减少30多。

与未处理的小鼠相比,处理的小鼠还具有显着降低的血液胆固醇和脂肪酸水平。

能够将药物直接输送到作用部位是药物不太可能产生副作用的主要原因。

该团队估计,他们的原型贴片的原材料成本约为5新加坡元(3.50美元),其中含有β-3肾上腺素能受体激动剂与透明质酸结合,透明质酸是一种天然存在于人体内的物质,常用于皮肤润肤霜。

β-3肾上腺素能受体激动剂是由美国联邦药物管理局批准的药物,用于治疗膀胱过动症,而T3三碘甲状腺原氨酸是一种甲状腺激素,通常用于治疗甲状腺功能低下的甲状腺。

在其他研究中都显示能够使白色脂肪变成棕色,但是如果使用常规的药物递送途径,则在非目标组织中潜在的严重副作用和药物积累妨碍了它们在减少体重增加方面的用途,例如通过口服摄入。

台大李光前医学院副教授梅尔文?利(Melvin Leow)与本研究无关,他表示能够通过褐变白色脂肪来解决肥胖问题令人兴奋,结果令人振奋。

“这些数据应该鼓励人类I期临床研究将这些基础科学发现转化为临床,希望这些微针贴片可以在不久的将来发展成为预防或治疗肥胖症的既定成本效益模式, “内分泌专家Leow副教授补充说。

自该论文发表以来,该团队一直受到生物技术公司的浓厚兴趣,正在寻求与临床科学家合作进一步研究。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1896234, encodeId=47581896234bd, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jun 23 12:07:00 CST 2018, time=2018-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314491, encodeId=6820314491a1, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJu1TYd7JWBGjYppT7VfHb1ZOJpOuhqvn8taH1InVxz4AaPNPeaIa6mTu8m7lHxtVyg71kYCHh11g/132, createdBy=43e62066419, createdName=cococo, createdTime=Sat May 12 18:55:55 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275108, encodeId=8de72e51088a, content=创新治疗方法.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jan 03 18:50:12 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329058, encodeId=d7af132905882, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388866, encodeId=6f1d13888666d, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16425, encryptionId=a75a1642585, topicName=SMA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273575, encodeId=6c142e357570, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Dec 29 17:26:02 CST 2017, time=2017-12-29, status=1, ipAttribution=)]
    2018-06-23 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1896234, encodeId=47581896234bd, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jun 23 12:07:00 CST 2018, time=2018-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314491, encodeId=6820314491a1, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJu1TYd7JWBGjYppT7VfHb1ZOJpOuhqvn8taH1InVxz4AaPNPeaIa6mTu8m7lHxtVyg71kYCHh11g/132, createdBy=43e62066419, createdName=cococo, createdTime=Sat May 12 18:55:55 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275108, encodeId=8de72e51088a, content=创新治疗方法.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jan 03 18:50:12 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329058, encodeId=d7af132905882, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388866, encodeId=6f1d13888666d, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16425, encryptionId=a75a1642585, topicName=SMA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273575, encodeId=6c142e357570, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Dec 29 17:26:02 CST 2017, time=2017-12-29, status=1, ipAttribution=)]
    2018-05-12 cococo

    已读

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1896234, encodeId=47581896234bd, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jun 23 12:07:00 CST 2018, time=2018-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314491, encodeId=6820314491a1, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJu1TYd7JWBGjYppT7VfHb1ZOJpOuhqvn8taH1InVxz4AaPNPeaIa6mTu8m7lHxtVyg71kYCHh11g/132, createdBy=43e62066419, createdName=cococo, createdTime=Sat May 12 18:55:55 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275108, encodeId=8de72e51088a, content=创新治疗方法.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jan 03 18:50:12 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329058, encodeId=d7af132905882, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388866, encodeId=6f1d13888666d, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16425, encryptionId=a75a1642585, topicName=SMA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273575, encodeId=6c142e357570, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Dec 29 17:26:02 CST 2017, time=2017-12-29, status=1, ipAttribution=)]
    2018-01-03 虈亣靌

    创新治疗方法.学习了.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1896234, encodeId=47581896234bd, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jun 23 12:07:00 CST 2018, time=2018-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314491, encodeId=6820314491a1, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJu1TYd7JWBGjYppT7VfHb1ZOJpOuhqvn8taH1InVxz4AaPNPeaIa6mTu8m7lHxtVyg71kYCHh11g/132, createdBy=43e62066419, createdName=cococo, createdTime=Sat May 12 18:55:55 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275108, encodeId=8de72e51088a, content=创新治疗方法.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jan 03 18:50:12 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329058, encodeId=d7af132905882, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388866, encodeId=6f1d13888666d, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16425, encryptionId=a75a1642585, topicName=SMA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273575, encodeId=6c142e357570, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Dec 29 17:26:02 CST 2017, time=2017-12-29, status=1, ipAttribution=)]
    2017-12-31 膀胱癌
  5. [GetPortalCommentsPageByObjectIdResponse(id=1896234, encodeId=47581896234bd, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jun 23 12:07:00 CST 2018, time=2018-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314491, encodeId=6820314491a1, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJu1TYd7JWBGjYppT7VfHb1ZOJpOuhqvn8taH1InVxz4AaPNPeaIa6mTu8m7lHxtVyg71kYCHh11g/132, createdBy=43e62066419, createdName=cococo, createdTime=Sat May 12 18:55:55 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275108, encodeId=8de72e51088a, content=创新治疗方法.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jan 03 18:50:12 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329058, encodeId=d7af132905882, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388866, encodeId=6f1d13888666d, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16425, encryptionId=a75a1642585, topicName=SMA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273575, encodeId=6c142e357570, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Dec 29 17:26:02 CST 2017, time=2017-12-29, status=1, ipAttribution=)]
    2017-12-31 江川靖瑶
  6. [GetPortalCommentsPageByObjectIdResponse(id=1896234, encodeId=47581896234bd, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jun 23 12:07:00 CST 2018, time=2018-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314491, encodeId=6820314491a1, content=已读, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJu1TYd7JWBGjYppT7VfHb1ZOJpOuhqvn8taH1InVxz4AaPNPeaIa6mTu8m7lHxtVyg71kYCHh11g/132, createdBy=43e62066419, createdName=cococo, createdTime=Sat May 12 18:55:55 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275108, encodeId=8de72e51088a, content=创新治疗方法.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jan 03 18:50:12 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329058, encodeId=d7af132905882, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388866, encodeId=6f1d13888666d, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16425, encryptionId=a75a1642585, topicName=SMA)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 31 07:07:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273575, encodeId=6c142e357570, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b0041939716, createdName=hhh678, createdTime=Fri Dec 29 17:26:02 CST 2017, time=2017-12-29, status=1, ipAttribution=)]
    2017-12-29 hhh678

    henhao

    0

相关资讯

Nat commun:突破:无痛皮肤贴针一周血糖正常,糖尿病患者告别药物和胰岛素

研究人员设计了一种生物化学配方的可溶解微针贴片,用于治疗2型糖尿病。补片中矿化化合物的生化公式响应血液化学自动管理葡萄糖。在对老鼠进行的一项概念研究中,研究人员发现,这些化学物质在血液中相互作用,一次可以调节血糖数天。

无痛微针贴剂将会代替传统针头

无痛微针贴剂进入我们的生活只是时间问题,在《公共科学图书馆》最新的期刊中登载了斯德哥尔摩皇家学院研究团队微针贴剂的成功研究。这一研究是把不锈钢针植入柔软的聚合物基中,这是第一次把这一实验提到科学研究中来,柔软的材料贴服的同时,也得保证其摄入性。与表皮针不同,微针接触的是皮肤表皮,避免接触到神经系统。它可以用于输液打针,提取身体物质的健康检查,血糖值,PH值,以及其他检查提取身体液体之外,还可以用